NCT02843256

Brief Summary

Carbon-12 and carbon-13 are naturally-occurring isotopes that are found in exhaled breath. Investigators have proved that the 13CO2/12CO2 breath delta value (BDV) changes in subjects who were in negative energy balance then fed a positive energy balance meal. Measuring one liter of exhaled breath daily may be a more convenient way to measure negative or positive energy balance in patients receiving intravenous nutrition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 6, 2016

Completed
2 days until next milestone

Study Start

First participant enrolled

June 8, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 25, 2016

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2017

Completed
Last Updated

November 28, 2017

Status Verified

November 1, 2017

Enrollment Period

1.1 years

First QC Date

June 6, 2016

Last Update Submit

November 26, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Variation in Breath Delta Value

    Investigators will test if the breath delta value (kJ) increases in subjects from baseline (pre-parenteral nutrition) to the subject's goal calculated rate. The time frame tested for each subject will be from baseline to 7 days or the length of parenteral nutrition (whichever is shorter.) Investigators will recruit 20 patients, and this may take 6 months to accomplish. This is a pilot investigation.

    baseline to day 7

Secondary Outcomes (3)

  • Variation in Breath Delta Value from day 0 to day 1 of parenteral nutrition

    day 0 to day 1

  • Subjects and Variation in Breath Delta Value

    baseline to day 7

  • Variation in Breath Delta Value when Parenteral Nutrition is interrupted

    baseline to day 7

Study Arms (1)

Patients receiving intravenous nutrition

Patients will blow into a bag that will capture 500 mL of their exhaled air daily for 7 days or the length of the parenteral nutrition, whichever is shorter. The Isomark Canary will analyze the air to generate a breath delta value.

Device: Isomark Canary

Interventions

The Isomark Canary will analyze the exhaled air and generate a breath delta value.

Patients receiving intravenous nutrition

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients (age 18 or order) with clinical indications for parenteral nutrition who are moderately to severely malnourished due to little to no nutrition by other means (oral nutrition or nutrition per tube) for a period of time (0-10 days based on state of nourishment prior to admission).

You may qualify if:

  • years of age or older
  • Anticipated start of parenteral nutrition
  • Expected duration of stay at least 5 days from enrollment
  • Subject speaks English
  • Subjects with inability to take adequate oral nutrition who are developing or have developed malnutrition who require parenteral nutrition

You may not qualify if:

  • Subjects unable to coordinate well enough to give a 1 liter breath sample
  • Subjects receiving parenteral nutrition prior to admission
  • Subjects who are pregnant
  • Subjects who are prisoners
  • Subjects who are pharmacologically sedated or with altered consciousness
  • Subjects who are mechanically ventilated
  • Subjects admitted for bone marrow or stem cell transplants
  • Known participation in another interventional research study within 30 days prior to enrollment (note: to be eligible, any interventional treatment must have ended at least 30 days ago)
  • Subjects with disease states or clinical conditions that do not make them study candidates, per the primary investigator's discretion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Wisconsin Hospital and Clinics

Madison, Wisconsin, 53792, United States

Location

MeSH Terms

Conditions

ObesityMalnutritionFasting

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsFeeding BehaviorBehavior

Study Officials

  • Kenneth A Kudsk, MD

    University of Wisconsin, Madison

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 6, 2016

First Posted

July 25, 2016

Study Start

June 8, 2016

Primary Completion

July 10, 2017

Study Completion

July 10, 2017

Last Updated

November 28, 2017

Record last verified: 2017-11

Locations